<

 
Data updated 2025-05-13 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date05713358.9 (espacenet)  (Federated)  (European Patent Register), 20050211
Patent/reg. no. and dateDK/EP 1715890, 20080709
Publication date20061102
Priority no. and dateUS 544121 P, 20040211, US 561018 P, 20040408, US 578401 P, 20040609, US 620802 P, 20041020
EP pub. no. and date EP 1715890 20061102
Effective date
Applicant/ownerFIBROGEN, INC., 772 Lucerne Drive, Sunnyvale, CA 94086 , US
Applicant ref. no.P44847DK01
InventorNEFF, Thomas, B., 190 Glenwood Avenue
Atherton, CA 94027, US,
OLIVER, Noelynn, A., 421 Mundel Way
Los Altos, CA 94022, US,
LIU, David, Y., 201 Ferne Avenue
Palo Alto, CA 94306, US,
USINGER, William, R., 1056 Roderick Court
Lafayette, CA 94549, US,
WANG, Qingjian, 37 Edgewood Place
Belmont, CA 94002, US,
FLYVBJERG, Allan, Asylgade 41, 8300 Odder, DK,
GUO, Guangjie, 22 Port Royal Avenue
Foster City, CA 94404, US
RepresentativePlougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK
Opponent
IPC ClassA61K 31/00 (2006.01) , A61K 38/00 (2006.01) , A61K 39/39 (2006.01) , A61K 39/395 (2006.01) , A61P 13/12 (2006.01) 
TitleCTGF som mål for mikroalbuminuriterapi hos patienter med diabetisk nefropati
Int. application no.US2005004367
Int. publication no.WO2005077413
Related patent (certificate)
StatusBortfaldet
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact